Palisade Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-62,928	Closed	-$2M	–	460
2016 Q3	$2M	Sell	62,928 -9,134	-13%	-$310K	0.07%	336
2016 Q2	$2.34M	Sell	72,062 -211,837	-75%	-$7.09M	0.08%	310
2016 Q1	$7.94M	Sell	283,899 -211,931	-43%	-$4.62M	0.26%	126
2015 Q4	$17.7M	Sell	495,830 -144,722	-23%	-$5.1M	0.57%	36
2015 Q3	$21.2M	Sell	640,552 -16,189	-2%	-$674K	0.62%	28
2015 Q2	$27.5M	Sell	656,741 -48,560	-7%	-$1.88M	0.7%	15
2015 Q1	$23M	Sell	705,301 -296,813	-30%	-$10.2M	0.58%	39
2014 Q4	$31.8M	Buy	1,002,114 +29,068	+3%	+$824K	0.77%	12
2014 Q3	$24.1M	Sell	973,046 -169,492	-15%	-$3.96M	0.61%	26
2014 Q2	$25.8M	Sell	1,142,538 -108,226	-9%	-$2.26M	0.62%	23
2014 Q1	$30.4M	Sell	1,250,764 -90,085	-7%	-$2.28M	0.75%	14
2013 Q4	$32.6M	Buy	1,340,849 +135,198	+11%	+$3.19M	0.85%	9
2013 Q3	$33.1M	Buy	1,205,651 +211,517	+21%	+$4.42M	0.9%	6
2013 Q2	$18M	Buy	+994,134	New	+$13.7M	0.52%	45